ClinicalTrials.gg
RecruitingNCT06923410Updated May 16, 2025

Clinical Intelligent Management System - Multilingual Exploration

An interventional study of AI model in Primary Care Diseases, sponsored by Tsinghua University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-05-16.

Sponsored by Tsinghua University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study aims to explore the diagnostic and therapeutic performance of a multimodal foundation model-based clinical intelligent management system in simulated outpatient scenarios. Specifically, it will compare the system's AI agent with general practitioners from different linguistic and cultural backgrounds worldwide, as well as various dialect and minority language regions in China.

The study will be conducted across multiple centers in diverse regions to comprehensively evaluate the system's adaptability. Using a prospective, single-blind design, each center will recruit primary care physicians.

Standardized simulated patients across all centers will be trained based on the same set of standardized cases and then will consult with four real physicians and the AI agent, ensuring consistency.

By comparing diagnostic and treatment quality, patient satisfaction, and clinical outcomes, this study aims to explore the system's effectiveness in enhancing primary care and patient management across different regions and linguistic environments.

02

Conditions studied

  • Primary Care Diseases
03

In context

Lead sponsor

Tsinghua University is the lead sponsor of 28 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion criteria for primary care physicians:

  • Fluent in the local languages spoken at each center.
  • With the general practice medical qualifications.
  • Agree to participate in the study and sign the form.

Inclusion criteria for simulated patient volunteers:

  • Age ≥ 18 years.
  • Fluent in the local languages spoken at each center.
  • Able to use electronic devices with intelligent systems.
  • Able to accurately express symptoms and participate throughout the process.
  • Agree to participate in the study and sign the informed consent form.

Exclision criteria: N/A

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    AI Agent Doctor group

    Standardized simulated patients consult with AI Agent Doctor, providing AI-generated diagnoses and treatments for health care.

    Device: AI model

  • No intervention
    Primary care physicians groups

    Standardized simulated patients consult with physicians, providing routine diagnoses and treatments as their usual standard health care.

Interventions

  • DeviceAI model

    The clinical intelligent AI system is equipped with an AI agent doctor, enabling patients to conduct self-consultations and receive care anytime and anywhere without the need for a real doctor.

06

What researchers measure

Primary outcomes

  1. Comprehensive Assessment of physician's clinical abilities

    Clinical Abilities Assessment Scales for Primary Care (range: 0 to 100 for each case; the higher scores means the better performance)

    Time frame: Immediately after the simulated consultation

Secondary outcomes

  1. System's Usability

    System Usability Evaluation Scale accessed by participating simulated patients, rated on a five-point Likert scale from strongly disagree (1) to strongly agree (5). (A higher scale value indicates higher perceived usability of the technology.)

    Time frame: Immediately after the simulated consultation with AI system

07

Study locations

1 of 1 sites recruiting
  • Tiantongyuan North Community Healthcare Center
    Beijing, Beijing 102218, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for Jun 2025, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2025
First posted
Apr 11, 2025
StartActual
Apr 15, 2025
Primary completionEst.
Jun 30, 2025
CompletionEst.
Jul 31, 2025
Last update
May 16, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06923410
Lead sponsor
Tsinghua University
Responsible party
Tien Yin Wong (Professor, Tsinghua University) — Principal investigator
First posted
Apr 11, 2025
Start date
Apr 15, 2025
Primary completion
Jun 30, 2025 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
May 16, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion